ANAVEX LIFE SCIENCES CORP. Annual Current Income Tax Expense (Benefit) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Anavex Life Sciences Corp. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Anavex Life Sciences Corp. Current Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$67K, a 263% decline year-over-year.
  • Anavex Life Sciences Corp. Current Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $59K, a 79% decline year-over-year.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2023 was $7K, a 98% decline from 2022.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2022 was $358K, a 33.6% increase from 2021.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2021 was $268K, a 1082% increase from 2020.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7K -$351K -98% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-27
2022 $358K +$90K +33.6% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-27
2021 $268K +$245K +1082% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-27
2020 $22.7K -$59.5K -72.4% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-28
2019 $82.2K +$9.44K +13% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-28
2018 $72.7K +$13.1K +22% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-16
2017 $59.6K +$30K +101% Oct 1, 2016 Sep 30, 2017 10-K/A 2019-01-25
2016 $29.6K Oct 1, 2015 Sep 30, 2016 10-K/A 2019-01-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.